Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria-Reference-Cited by-同舟云学术

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria

Published:2022-12 Issue:6 Volume:150 Page:1498-1506.e2
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Maurer Marcus,Berger William,Giménez-Arnau Ana,Hayama Koremasa,Jain Vipul,Reich Adam,Haemmerle Sibylle,Lheritier Karine,Walsh Pauline,Xia Summer,Storim Julian

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. The urticarias: pathophysiology and management;Grattan;Clin Med (Lond),2012

2. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria;Zuberbier;Allergy,2022

3. The global burden of chronic urticaria for the patient and society;Goncalo;Br J Dermatol,2021

4. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report;Maurer;Allergy,2011

5. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU;Maurer;Allergy,2017

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials;Clinical Drug Investigation;2024-09-06

2. Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

3. Prevention of exercise-induced anaphylaxis by ibrutinib;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

4. The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease;Expert Opinion on Pharmacotherapy;2024-08-12

5. Urticaria Management in North America: What We Know and What We Do Not Know;Current Treatment Options in Allergy;2024-08-06